Reports

• New York Did Not Fully Comply With Federal and State Requirements for Reporting and Monitoring Critical Incidents Involving Medicaid Beneficiaries With Developmental Disabilities

  

• Illinois Made Capitation Payments to Managed Care Organizations for Medicaid Beneficiaries With Concurrent Eligibility in Another State

  

• Opioid Use in Medicare Part D During the Onset of the COVID-19 Pandemic

  

• Louisiana Did Not Correctly Determine Medicaid Eligibility for Some Newly Enrolled Beneficiaries

  

• California Claimed at Least $2 Million in Unallowable Medicaid Reimbursement for a Selected Providers Opioid Treatment Program Services

  

• Massachusetts Made at Least $14 Million in Improper Medicaid Payments for the Nonemergency Medical Transportation Program

  

• Medicare Home Health Agency Provider Compliance Audit: Southeastern Home Health Services

  

• Independent Attestation Review: Centers for Disease Control and Prevention Fiscal Year 2020 Detailed Accounting Report, Performance Summary Report for National Drug Control Activities, Budget Formulation Compliance Report, and Accompanying Required Assertions

  

• Independent Attestation Review: Health Resources and Services Administration Fiscal Year 2020 Detailed Accounting Report, Performance Summary Report for National Drug Control Activities, Budget Formulation Compliance Report, and Accompanying Required Assertions

  

• Ohio Made Progress Toward Achieving Program Goals for Enhancing Its Prescription Drug Monitoring Program

  

• The Centers for Medicare & Medicaid Services Could Improve Its Wage Index Adjustment for Hospitals in Areas With the Lowest Wages

  

• Medicare Home Health Agency Provider Compliance Audit: Tender Touch Health Care Services

  

• Medicare Hospice Provider Compliance Audit: Hospice Compassus, Inc., of Tullahoma, Tennessee

  

• Advisory Opinion 20-05

  

• CMS Should Pursue Strategies To Increase the Number of At Risk Beneficiaries Acquiring Naloxone Through Medicaid

  

• Oregon Oversight Did Not Ensure That Four Coordinated-Care Organizations Complied With Selected Medicaid Requirements Related to Access to Care and Quality of Care

  

• Incorrect Acute Stroke Diagnosis Codes Submitted by Traditional Medicare Providers Resulted in Millions of Dollars in Increased Payments to Medicare Advantage Organizations

  

• Maine Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs

  

• Some Manufacturers Reported Inaccurate Drug Product Data to CMS

  

• Billions in Estimated Medicare Advantage Payments From Diagnoses Reported Only on Health Risk Assessments Raise Concerns